Hutchison MediPharma is a pharmaceutical research and development ("R&D") company and aims to bring novel drugs to the global market for the treatment of cancer and auto-immune diseases by using modern drug discovery and development technologies and clinical standards that meet the requirements of ICH guidelines. Hutchison MediPharma has a fully integrated drug discovery and development infrastructure and cutting-edge drug discovery platforms. Over a short period of time, the company has established a rich portfolio of preclinical and clinical candidates and has formed strategic alliances with global leading pharmaceutical giants.

Hutchison MediPharma's competitive advantages lie in the following areas: